Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$1.11 Mil
% of Total Estimate Gain
5.47%

SILVERARC CAPITAL MANAGEMENT, LLC's Cogent Biosciences Inc Holding Summary

As of 2025-03-31, SILVERARC CAPITAL MANAGEMENT, LLC held - shares of Cogent Biosciences Inc(COGT), totaling N/A. This investment constitutes 0% of their stock portfolio, and SILVERARC CAPITAL MANAGEMENT, LLC now holds 0% of the outstanding Cogent Biosciences Inc(COGT) stock.

The initial trade took place in 2020Q4. And since then SILVERARC CAPITAL MANAGEMENT, LLC has made 11 purchases of COGT, at an average price of $9.03, for a total of 2.26 Mil shares. In addition, there have been 6 sales at an average price of $9.53 for 2.26 Mil shares. Based on historical transaction data and COGT's current price of $12.49, SILVERARC CAPITAL MANAGEMENT, LLC's estimated gain on his COGT holdings is $1.11 Mil, reflecting a 5.47% gain to date.

SILVERARC CAPITAL MANAGEMENT, LLC COGT ($12.49) Holding Chart

SILVERARC CAPITAL MANAGEMENT, LLC COGT ($12.49) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1